Reports
Reports
Make A Forward-looking Plan With High-yielding Investments
Total Reports: 100
The principal driver to the PCR and real-time PCR molecular diagnostics market is automation and demand for high throughput.
Rep Id : TMRGL79197 | Published | Healthcare | December 2025
The SNP genotyping and analysis market has escalated in volume over the past few years, in step with the rise of genomic technologies and the spreading of the concept of personalized medicine.
Rep Id : TMRGL432 | Published | Healthcare | December 2025
The cell free RNA (cfRNA) diagnostics market is set to grow substantially.
Rep Id : TMRGL86866 | Published | Healthcare | December 2025
The global gastric cancer diagnostics market size was valued at US$ 3.5 billion in 2024 and is projected to reach US$ 6.9 billion by 2035, expanding at a CAGR of 6.4% from 2025 to 2035.
Rep Id : TMRGL86864 | Published | Healthcare | December 2025
The market for antibody specificity testing is undergoing a remarkable expansion due to the progressive biotechnological innovations and the ever-increasing demand for accurate diagnostic tools.
Rep Id : TMRGL86863 | Published | Healthcare | December 2025
The gene fusion testing market is set to experience substantial expansion over the next few years, largely due to the continuous upgradations in genomic technologies and increased involvement of gene fusion in different cancers.
Rep Id : TMRGL86836 | Published | Healthcare | November 2025
The thyroid cancer diagnostics market is experiencing significant growth towing to the rising prevalence of thyroid cancer, increasing focus on early detection, and rising adoption of personalized medicine.
Rep Id : TMRGL78729 | Published | Healthcare | November 2025
Technological innovations in diagnostic methods are amongst the significant factors driving the ovarian cancer diagnostics market.
Rep Id : TMRGL43469 | Published | Healthcare | November 2025
The global specimen collection cards market functions as a continuously expanding division of the diagnostic and clinical testing industry.
Rep Id : TMRGL86803 | Published | Healthcare | November 2025
The global market for lateral-flow-assay (LFA) is a response to the increasing demand for point-of-care diagnostics, materials innovation, and decentralized delivery of healthcare.
Rep Id : TMRGL39356 | Published | Healthcare | November 2025
The infectious disease rapid diagnostics devices market is growing on a staggering note under the influence of a chain of critical drivers.
Rep Id : TMRGL86762 | Published | Healthcare | October 2025
The in vitro diagnostics (IVD) market globally continues to grow steadily driven by increased prevalence of chronic and infectious disease, increased cognition and demand for earlier and more accurate disease detection, along with rapid advancement in IVD technologies including molecular diagnostics, next-gen sequencing (NGS), and point-of-care testing (POCT).
Rep Id : TMRGL12959 | Published | Healthcare | September 2025
The global blood testing market is driven by several dynamics: the growing rates of chronic and infectious disease including diabetes, cardiovascular disease, and cancer, increase in aging population, and the rising interest in preventive and personalized medicine.
Rep Id : TMRGL2517 | Published | Healthcare | September 2025
The exosome technology market is increasingly being driven by rapid developments in molecular biology and biotechnology, especially in personalized medicine.
Rep Id : TMRGL65840 | Published | Healthcare | September 2025
The molecular diagnostics market is expanding at a rapid pace due to rise in incidence of infectious diseases and cancer along with increasing frequency of genetic disorders, thereby resulting in increased need for quick and precise diagnostics
Rep Id : TMRGL1783 | Published | Healthcare | September 2025
The microbiology culture market is witnessing steadiness due to applications in clinical diagnostics, food testing, pharmaceuticals, and environmental testing. A growing emphasis on pathogen detection and contamination prevention, along with concentration on R&D, has pushed demand for different culture methods higher.
Rep Id : TMRGL3232 | Published | Healthcare | July 2025
Rising prevalence of Down syndrome cases and growing maternal age and associated chromosomal risks are driving the non-invasive prenatal testing market demand. Moreover, physicians are choosing advanced DNA-based screening methods like NIPT due to their high safety, accuracy, and early screening for chromosomal abnormalities in pregnancy.
Rep Id : TMRGL374 | Published | Healthcare | May 2025
Surging volume of organ transplantation procedures, technological advancements in molecular diagnostics, genetic testing, identification of biomarkers, awareness among masses regarding the requirement for organ transplantation and supportive policies and regulations made by the government are some of the key trends bound to propel the transplant diagnostics market size.
Rep Id : TMRGL20225 | Published | Healthcare | May 2025
Medical radioisotopes market is expanding exponentially and immensely influenced by the increasing demand for diagnostic imaging and therapeutic usage of medical practice The increasing incidence of chronic diseases such as cancer and cardiovascular disease is increasing demand for sophisticated imaging modalities such as positron emission tomography (PET) and single-photon emission
Rep Id : TMRGL86586 | Published | Healthcare | April 2025
Drivers of the cancer diagnostics market include growing cases of cancer globally, increasing demand for early detection, technological advancements in liquid biopsy, molecular diagnostics, and AI-based imaging. Government policies, expanding applications of precision medicine and expanding awareness also contribute to market expansion.
Rep Id : TMRGL3637 | Published | Healthcare | April 2025
Advancements in genetic testing technology and increased awareness and early detection of genetic disorders are some of the leading factors driving carrier screening market growth. Carrier screening Carrier screening is a diagnostic test used to identify individuals who carry genetic mutations for inherited diseases.
Rep Id : TMRGL86568 | Published | Healthcare | March 2025
The major factors driving the growth of the UAE clinical laboratory services market include the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer, which require early diagnosis and ongoing monitoring using diagnostic laboratory services. Besides, advanced technologies, including AI diagnostics and molecular testing, transform the working
Rep Id : TMRGL23354 | Published | Healthcare | December 2024
The increasing incidence of infections acquired in healthcare settings has prompted a growing emphasis on culture tests as essential diagnostic tools. With the growing volume of surgical procedures and hospital admissions across Europe and the MEA region, the risk of healthcare-associated infections also rises, leading to higher morbidity, mortality as
Rep Id : TMRGL86426 | Published | Healthcare | December 2024
Analysts view the syphilis immunoassay diagnostics market as a dynamic and growing sector, primarily driven by the rising prevalence of syphilis cases globally and increased awareness surrounding sexually transmitted infections (STIs).
Rep Id : TMRGL2140 | Published | Healthcare | November 2024
Increase in incidence of lung cancer, especially in developing countries, is the key driver of the global lung cancer diagnostics market. Surge in awareness about the importance of early and accurate diagnosis of this cancer is expected to accelerate industry development.
Rep Id : TMRGL74159 | Published | Healthcare | October 2024
Global In-Vitro Inflammatory Bowel Disease (IBD) diagnostics market is growing rapidly because it has become increasingly common to find the cases of Crohn’s disease and ulcerative colitis worldwide. The major trends affecting this space are the introduction of new diagnostic techniques including non-invasive tests with better accuracy and patient comfort
Rep Id : TMRGL74162 | Published | Healthcare | September 2024
Growth in demand for personalized medicine, surge in prevalence of chronic diseases, increase in use of metabolomics approaches in drug discovery, rise in investments in R&D activities, and advent of innovative analytical instruments and software are driving the metabolomics market growth.
Rep Id : TMRGL903 | Published | Healthcare | June 2024
Colon cancer, which is caused by cancer of the colon and rectum, ranks third in worldwide mortality charts according to the World Health Organization (WHO).
Rep Id : TMRGL3698 | Published | Healthcare | June 2024
The large number of surgical procedures conducted globally is expected to bolster the hemostasis products market growth as a practical solution related to blood management.
Rep Id : TMRGL13880 | Published | Healthcare | June 2024
Increase in prevalence and incidence of sexually transmitted diseases (STDS) globally is anticipated to be a key driver of the market. STD is predominant in lower and middle income countries and hence governments have been taken up various awareness programs and activities related to prevention and spread of STDs.
Rep Id : TMRGL1207 | Published | Healthcare | May 2024
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
